Svb Wealth LLC Blueprint Medicines Corp Transaction History

Svb Wealth LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$41.06 - $66.48 $29,645 - $47,998	-722 Reduced 8.78%	7,505 $328,000
Q3 2022 Nov 09, 2022	BUY	$49.93 - $77.7 $848 - $1,320	17 Added 0.21%	8,227 $542,000
Q1 2022 May 13, 2022	SELL	$54.1 - $110.08 $486 - $990	-9 Reduced 0.11%	8,210 $525,000
Q4 2021 Feb 15, 2022	BUY	$94.25 - $115.99 $659 - $811	7 Added 0.09%	8,219 $880,000
Q3 2021 Nov 09, 2021	SELL	$80.98 - $109.47 $88,106 - $119,103	-1,088 Reduced 11.7%	8,212 $844,000
Q2 2021 Aug 13, 2021	BUY	$82.78 - $101.0 $58,856 - $71,811	711 Added 8.28%	9,300 $818,000
Q1 2021 May 11, 2021	BUY	$90.71 - $108.28 $98,783 - $117,916	1,089 Added 14.52%	8,589 $835,000
Q3 2020 Nov 10, 2020	BUY	$66.45 - $92.7 $498,375 - $695,250	7,500 New	7,500 $695,000

351

60.3M

2.25M

1.18M

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

Get notified when there are updates to the investment portfolio of Svb Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Svb Wealth LLC with notifications on news.